The SUPR-CM is a high-throughput protein stability screening system with applications in antibody engineering and formulation.
Understanding the comparable stability of antibodies is an essential stage in identifying the most likely candidates to succeed in the engineering process for biotherapeutics.
The stability of modified variants can be assessed via chemical denaturation measurements with the SUPR-CM, which can also reveal unique insights not seen by other methods. These measurements will be discussed within the context of the biologic development process in order to illustrate how the SUPR-CM can enhance the processes within development of future biotherapeutics.
Date: Aug 04, 2020
Time: 04:00 pm BST
Watch the recorded webinar below!